EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in Parkinson’s disease medication prescribing patterns in the UK: An interrupted time series analysis (2019–2024)

Khalid Orayj iD

PLOS One · 23.05.2025 · 20 (5) · e0324999

DOI: 10.1371/journal.pone.0324999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 23.05.2025. Verfasst von Khalid Orayj. Beteiligte Einrichtung: Clinical Pharmacy Department, School of Pharmacy, King Khalid University, Abha, Saudi Arabia. Hauptthemen laut MEDLINE: Parkinson Disease, Levodopa, Practice Patterns, Physicians', Antiparkinson Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to examine prescribing trends for Parkinson’s disease (PD) medications in the United Kingdom from 2019 to 2024, focusing on the impact of guidelines from the American Academy of Neurology (AAN) and the National Institute for Health and Care Excellence (NICE) on the use of levodopa and dopamine agonists (DAs). A repeated cross-sectional design was employed, using publicly available data to assess prescribing patterns across the four UK countries. An interrupted time series analysis with linear regression was performed to identify trends, comparing regions with England as the reference point. Levodopa remained the most prescribed PD medication across all UK regions, as revealed by the analysis. In England, levodopa prescriptions increased significantly after the introduction of AAN guidelines, while other regions displayed more stable trends. Northern Ireland exhibited a distinct pattern, with DAs prescribed more frequently than levodopa. The findings also indicated that Scotland and Wales were less responsive to AAN guidance. This study highlights the influence of clinical guidelines on PD prescribing practices in the UK, with regional variations suggesting possible demographic or healthcare system factors. Further research is required to understand these disparities and their implications for PD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseLevodopaPractice Patterns, Physicians'Antiparkinson AgentsDopamine AgonistsDrug PrescriptionsHumansInterrupted Time Series AnalysisUnited KingdomCross-Sectional StudiesPractice Guidelines as Topic

Substanzen

LevodopaAntiparkinson AgentsDopamine Agonists

Autor:innen und Institutionen

  • Clinical Pharmacy Department, School of Pharmacy, King Khalid University, Abha, Saudi Arabia.

ORCID-Profile: Khalid Orayj

Förderung

  • Deanship of Scientific Research, King Khalid University

Zitieren

APA

Orayj, K. (2025). Trends in Parkinson’s disease medication prescribing patterns in the UK: An interrupted time series analysis (2019–2024). PLOS One, 20(5), e0324999. https://doi.org/10.1371/journal.pone.0324999

Vancouver

Orayj K. Trends in Parkinson’s disease medication prescribing patterns in the UK: An interrupted time series analysis (2019–2024). PLOS One. 2025;20(5):e0324999. doi:10.1371/journal.pone.0324999

BibTeX
@article{Orayj2025,
  author = {Orayj, Khalid},
  title = {Trends in Parkinson’s disease medication prescribing patterns in the UK: An interrupted time series analysis (2019–2024)},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {5},
  pages = {e0324999},
  doi = {10.1371/journal.pone.0324999}
}
Kostenlos starten →